Risk factors and preventive interventions for post Covid-19 condition: systematic review

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard. WHO; 2021. [cited 2021 Dec 10]. Available from: https://covid19.who.int/
   Google Scholar
• Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network – United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–998.
   PubMed Web of Science ®Google Scholar
• Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.
   PubMedGoogle Scholar
• Kayaaslan B, Eser F, Kalem AK, et al. Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. 2021;93(12):6566–6574.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Post-COVID conditions. Washington (DC): CDC; 2021. [cited 2021 Dec 14]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Flong-term-effects.html
   Google Scholar
• Shah W, Hillman T, Playford ED, et al. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. Br Med J. 2021;372:n136.
   PubMedGoogle Scholar
• The Lancet (Editorial). Facing up to long COVID. Lancet (London, England). 2020;396(10266):1861.
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.
   PubMed Web of Science ®Google Scholar
• World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus; 2021 Oct 6.
   Google Scholar
• Akbarialiabad H, Taghrir MH, Abdollahi A, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163–1186.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 2 December 2021. Estimates of the prevalence of self-reported long COVID and associated activity limitation, using UK coronavirus (COVID-19) infection survey data. Office for National Statistics; 2021.
   Google Scholar
• Domingo FR, Waddell LA, Cheung AM, et al. Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review; 2021. [cited 2021 Dec 14]. Available from: https://www.medrxiv.org/content/10.11012021.06.03.21258317v2.article-info
   Google Scholar
• Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427.
   PubMed Web of Science ®Google Scholar
• Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232.
   PubMed Web of Science ®Google Scholar
• Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. 2021;8:100186.
   PubMedGoogle Scholar
• Boscolo-Rizzo P, Guida F, Polesel J, et al. Long COVID in adults at 12 months after mild-to-moderate SARS-CoV-2 infection; 2021.
   Google Scholar
• Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One. 2021;16(7):e0254523.
   PubMed Web of Science ®Google Scholar
• Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507–1513.
   PubMed Web of Science ®Google Scholar
• Frontera JA, Yang D, Lewis A, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021;426:117486.
   PubMed Web of Science ®Google Scholar
• Carson G. Research priorities for long Covid: refined through an international multi-stakeholder forum. BMC Med. 2021;19(1):84.
   PubMed Web of Science ®Google Scholar
• Wise J. Long Covid: WHO calls on countries to offer patients more rehabilitation. Br Med J. 2021;372:n405.
   PubMedGoogle Scholar
• National Institutes of Health. NIH launches new initiative to study “long COVID”. NIH; 2021. [cited 2021 Dec 15]. Available from: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid
   Google Scholar
• Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions. Higgins JPT, Thomas J, Chandler J, et al., editors. 2nd ed. Chichester: Wiley; 2019.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Gates M, Pillay J, Wingert A, et al. Risk factors associated with severe outcomes of COVID-19: an updated rapid review to inform national guidance on vaccine prioritization in Canada. medRxiv; 2021. Available from: https://www.medrxiv.org/content/10.11012021.04.23.21256014v4
   Google Scholar
• WHO Working Group on the Clinical Characterisation and Management of COVID-19 Infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–e197.
   PubMed Web of Science ®Google Scholar
• Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394.
   PubMed Web of Science ®Google Scholar
• McGowan J, Sampson M, Salzwedel DM, et al. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–46.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), Royal College of General Practitioners (RCGP). Covid-19 rapid guideline: managing the long-term effects of Covid-19. NICE; 2021.
   Google Scholar
• Tufanaru C, Munn Z, Aromataris E, et al. Chapter 3: systematic reviews of effectiveness. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute reviewer’s manual. Joanna Briggs Institute; 2017.
   Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. Br Med J. 2019;366:l4898.
   PubMed Web of Science ®Google Scholar
• Murad MH, Mustafa RA, Schünemann HJ, et al. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85–87.
   PubMedGoogle Scholar
• Iorio A, Spencer FA, Falavigna M, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. Br Med J. 2015;350:h870.
   PubMed Web of Science ®Google Scholar
• Foroutan F, Guyatt G, Zuk V, et al. GRADE guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. J Clin Epidemiol. 2020;121:62–70.
   PubMed Web of Science ®Google Scholar
• Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607–1613.
   PubMed Web of Science ®Google Scholar
• Liu Y-H, Wang Y-R, Wang Q-H, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16(1):48.
   PubMed Web of Science ®Google Scholar
• Munblit D, Bobkova P, Spiridonova E, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19. Clin Exp Allergy. 2021;51:1107–1120.
   PubMed Web of Science ®Google Scholar
• Nehme M, Braillard O, Chappuis F, et al. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021;174(9):1252–1260.
   PubMed Web of Science ®Google Scholar
• Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for long Covid in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J. 2021;59(2):2101341.
   Web of Science ®Google Scholar
• Qin W, Chen S, Hu B, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021;58(1):036772020.
   Web of Science ®Google Scholar
• Qu G, Sun Y, Zhen Q, et al. Health-related quality of life of COVID-19 patients after discharge: a multicenter follow-up study. J Clin Nurs. 2021;30(11–12):1742–1750.
   PubMed Web of Science ®Google Scholar
• Shang YF, Yu JN, Xu XR, et al. Half-year follow-up of patients recovering from severe COVID-19: analysis of symptoms and their risk factors. J Intern Med. 2021;290(2):444–450.
   PubMed Web of Science ®Google Scholar
• Stavem K, Einvik G, Ghanima W, et al. Prevalence and determinants of fatigue after Covid-19 in non-hospitalized subjects: a population-based study. Int J Environ Health Res. 2021;18(4):1–11.
   Web of Science ®Google Scholar
• Westerlind E, Palstam A, Sunnerhagen KS, et al. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21(1):1023.
   PubMed Web of Science ®Google Scholar
• Amini A, Vaezmousavi M, Shirvani H. The effectiveness of cognitive-motor training on reconstructing cognitive health components in older male adults, recovered from the COVID-19. Neurol Sci. 2022;43(2):1395–1403.
   PubMed Web of Science ®Google Scholar
• Anastasio F, Barbuto S, Scarnecchia E, et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur Respir J. 2021;58(3):2004015.
   PubMed Web of Science ®Google Scholar
• Benzakour L, Braillard O, Mazzola V, et al. Impact of peritraumatic dissociation in hospitalized patients with COVID-19 pneumonia: a longitudinal study. J Psychiatr Res. 2021;140:53–59.
   PubMed Web of Science ®Google Scholar
• Feng G, Shi L, Huang T, et al. Human umbilical cord mesenchymal stromal cell treatment of severe COVID-19 patients: a 3-month follow-Up study following hospital discharge. Stem Cells Dev. 2021;30(15):773–781.
   PubMed Web of Science ®Google Scholar
• Gherlone EF, Polizzi E, Tete G, et al. Frequent and persistent salivary gland ectasia and oral disease after COVID-19. J Dent Res. 2021;100(5):464–471.
   PubMed Web of Science ®Google Scholar
• Jain E, Harmon EY, Sonagere MB. Functional outcomes and post-discharge care sought by patients with COVID-19 compared to matched controls after completing inpatient acute rehabilitation. PM R. 2021;13(6):618–625.
   PubMedGoogle Scholar
• Kataria S, Sharma P, Ram JP, et al. A pilot clinical study of an add-on ayurvedic formulation containing Tinospora cordifolia and Piper longum in mild to moderate COVID-19. J Ayurveda Integr Med. 2022;13(2):100454.
   PubMed Web of Science ®Google Scholar
• Li L, Gou CY, Li XM, et al. Effects of Chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge: a prospective cohort and nested case-control study. Chin J Integr Med. 2021;27(4):245–251.
   PubMed Web of Science ®Google Scholar
• Martin I, Braem F, Baudet L, et al. Follow-up of functional exercise capacity in patients with COVID-19: it is improved by telerehabilitation. Respir Med. 2021;183:106438.
   PubMed Web of Science ®Google Scholar
• Meije Y, Duarte-Borges A, Sanz X, et al. Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study. Clin Microbiol Infect. 2021;27(8):1151–1157.
   PubMed Web of Science ®Google Scholar
• Vetrici MA, Mokmeli S, Bohm AR, et al. Evaluation of adjunctive photobiomodulation (PBMT) for COVID-19 pneumonia via clinical status and pulmonary severity indices in a preliminary trial. J Inflamm Res. 2021;14:965–979.
   PubMed Web of Science ®Google Scholar
• Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747–754.
   PubMed Web of Science ®Google Scholar
• Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89–95.
   PubMed Web of Science ®Google Scholar
• Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.
   PubMedGoogle Scholar
• Castanares-Zapatero D, Kohn L, Dauvrin M, et al. Long COVID: pathophysiology – epidemiology and patient needs. Brussels: Health Services Research (HSR). Brussels: Belgian Health Care Knowledge Centre (KCE); 2021. Contract No.: KCE Reports 344. D/2021/10.273/31.
   Google Scholar
• Covid-19 Scientific Advisory Group. Rapid evidence report: updated review of prolonged symptoms after acute COVID-19 infection. Alberta: Alberta Health Services; 2021.
   Google Scholar
• Sullivan GM, Feinn R. Using effect size-or why the p value is not enough. J Grad Med Educ. 2012;4(3):279–282.
   PubMedGoogle Scholar
• Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-Covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ (Clin Res ed). 2021;372:n693.
   PubMedGoogle Scholar
• Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631.
   PubMed Web of Science ®Google Scholar
• Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19(1):274.
   PubMedGoogle Scholar
• English KC, Espinoza J, Pete D, et al. A comparative analysis of telephone and in-person survey administration for public health surveillance in rural American Indian communities. J Public Health Manag Pract. 2019;25(Suppl 5):S70–S76.
   PubMedGoogle Scholar
• de Sire A, Andrenelli E, Negrini F, et al. Rehabilitation and COVID-19: a rapid living systematic review by Cochrane rehabilitation field updated as of December 31st, 2020 and synthesis of the scientific literature of 2020. Eur J Phys Rehabil Med. 2021;57(2):181–188.
   PubMed Web of Science ®Google Scholar
• Curci C, Negrini F, Ferrillo M, et al. Functional outcome after inpatient rehabilitation in postintensive care unit COVID-19 patients: findings and clinical implications from a real-practice retrospective study. Eur J Phys Rehabil Med. 2021;57(3):443–450.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhang W, Yang Y, et al. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther Clin Pract. 2020;39:101166.
   PubMed Web of Science ®Google Scholar
• Hameed F, Palatulan E, Jaywant A, et al. Outcomes of a COVID-19 recovery program for patients hospitalized with SARS-CoV-2 infection in New York City: a prospective cohort study. PM R. 2021;13(6):609–617.
   PubMedGoogle Scholar
• Belcaro G, Cornelli U, Cesarone MR, et al. Preventive effects of Pycnogenol(R) on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19). Minerva Med. 2022;113(2):300–308.
   PubMed Web of Science ®Google Scholar
• Cesarone MR, Hu S, Belcaro G, et al. Pycnogenol(R)-Centellicum(R) supplementation improves lung fibrosis and post-COVID-19 lung healing. Minerva Med. 2022;113(1):135–140.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Coronavirus (COVID-19) vaccination and self-reported long COVID in the UK. Office of National Statistics; 2021 Oct 25.
   Google Scholar
• Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55.
   PubMed Web of Science ®Google Scholar
• Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. medRxiv; 2021. DOI:10.1101/2021.10.26.21265508
   Google Scholar
• Kuodi P, Gorelik Y, Zayyad H, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv; 2022. DOI:10.1101/2022.01.05.22268800
   Google Scholar
• Arnold D, Milne A, Samms E, et al. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series. Ann Intern Med. 2021;174(9):1334–1336.
   PubMed Web of Science ®Google Scholar
• Massey D, Berrent D, Akrami A, et al. Change in symptoms and immune response in people with post-acute sequelae of SARS-Cov-2 infection (PASC) after SARS-Cov-2 vaccination. medRxiv; 2021. DOI:10.1101/2021.07.21.21260391
   Google Scholar